Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Apyx Medical Corporation stock logo
APYX
Apyx Medical
$2.29
+6.7%
$1.61
$0.76
$2.35
$86.69M1.3181,680 shs78,454 shs
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
$14.80
-3.4%
$16.51
$11.13
$25.00
$995.33M1.56184,907 shs99,122 shs
Soliton, Inc. stock logo
SOLY
Soliton
$22.58
$21.55
$7.40
$22.60
$487.66M0.19347,827 shsN/A
Venus Concept Inc. stock logo
VERO
Venus Concept
$2.62
-11.4%
$2.41
$2.10
$14.50
$3.71M0.07693,011 shs241,125 shs
Beyond Air, Inc. stock logo
XAIR
Beyond Air
$0.18
+0.7%
$0.19
$0.15
$0.68
$15.46M0.221.54 million shs702,165 shs
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Apyx Medical Corporation stock logo
APYX
Apyx Medical
+6.70%+2.41%+41.60%+131.72%+71.19%
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
-3.42%-0.63%-16.07%-1.88%+28.21%
Soliton, Inc. stock logo
SOLY
Soliton
0.00%0.00%0.00%0.00%0.00%
Venus Concept Inc. stock logo
VERO
Venus Concept
-11.36%+18.86%+9.87%+10.81%-61.03%
Beyond Air, Inc. stock logo
XAIR
Beyond Air
+0.67%+9.61%-4.69%-25.91%-69.70%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Apyx Medical Corporation stock logo
APYX
Apyx Medical
1.7295 of 5 stars
0.05.00.04.20.01.70.6
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
0.75 of 5 stars
0.00.00.04.20.04.20.0
Soliton, Inc. stock logo
SOLY
Soliton
N/AN/AN/AN/AN/AN/AN/AN/A
Venus Concept Inc. stock logo
VERO
Venus Concept
1.2098 of 5 stars
0.02.00.00.02.53.30.6
Beyond Air, Inc. stock logo
XAIR
Beyond Air
3.9265 of 5 stars
3.73.00.03.51.10.80.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Apyx Medical Corporation stock logo
APYX
Apyx Medical
2.67
Moderate BuyN/AN/A
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
0.00
N/AN/AN/A
Soliton, Inc. stock logo
SOLY
Soliton
0.00
N/AN/AN/A
Venus Concept Inc. stock logo
VERO
Venus Concept
0.00
N/AN/AN/A
Beyond Air, Inc. stock logo
XAIR
Beyond Air
3.33
Buy$1.50737.99% Upside

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Apyx Medical Corporation stock logo
APYX
Apyx Medical
$48.10M1.80N/AN/A$0.38 per share6.04
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
$700K1,421.90N/AN/A$1.87 per share7.91
Soliton, Inc. stock logo
SOLY
Soliton
N/AN/AN/AN/A$1.46 per shareN/A
Venus Concept Inc. stock logo
VERO
Venus Concept
$64.83M0.06N/AN/A$4.30 per share0.61
Beyond Air, Inc. stock logo
XAIR
Beyond Air
$3.70M4.18N/AN/A$0.17 per share1.05
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Apyx Medical Corporation stock logo
APYX
Apyx Medical
-$23.46M-$0.55N/AN/AN/A-42.37%-156.85%-31.92%8/6/2025 (Estimated)
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
-$53.58MN/A0.00N/AN/A-68.44%-58.17%8/14/2025 (Estimated)
Soliton, Inc. stock logo
SOLY
Soliton
-$14.54M-$1.01N/AN/AN/AN/A-71.85%-62.92%N/A
Venus Concept Inc. stock logo
VERO
Venus Concept
-$47M-$76.30N/AN/A-81.26%-752.29%-54.52%8/12/2025 (Estimated)
Beyond Air, Inc. stock logo
XAIR
Beyond Air
-$46.62M-$0.79N/AN/AN/A-1,258.46%-233.96%-113.92%8/5/2025 (Estimated)

Latest SOLY, PLSE, XAIR, VERO, and APYX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
6/17/2025Q4 2025
Beyond Air, Inc. stock logo
XAIR
Beyond Air
-$0.14-$0.09+$0.05-$0.09$1.39 million$1.15 million
5/15/2025Q1 2025
Venus Concept Inc. stock logo
VERO
Venus Concept
-$14.08-$17.44-$3.36-$17.44$14.59 million$13.64 million
5/8/2025Q1 2025
Apyx Medical Corporation stock logo
APYX
Apyx Medical
-$0.13-$0.10+$0.03-$0.10$9.39 million$9.43 million
5/8/2025Q1 2025
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
N/A-$0.25N/A-$0.25N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Apyx Medical Corporation stock logo
APYX
Apyx Medical
N/AN/AN/AN/AN/A
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
N/AN/AN/AN/AN/A
Soliton, Inc. stock logo
SOLY
Soliton
N/AN/AN/AN/AN/A
Venus Concept Inc. stock logo
VERO
Venus Concept
N/AN/AN/AN/AN/A
Beyond Air, Inc. stock logo
XAIR
Beyond Air
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Apyx Medical Corporation stock logo
APYX
Apyx Medical
3.21
5.45
4.64
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
N/A
15.58
15.58
Soliton, Inc. stock logo
SOLY
Soliton
N/A
5.47
5.37
Venus Concept Inc. stock logo
VERO
Venus Concept
7.91
1.28
0.79
Beyond Air, Inc. stock logo
XAIR
Beyond Air
0.64
3.20
2.72

Institutional Ownership

CompanyInstitutional Ownership
Apyx Medical Corporation stock logo
APYX
Apyx Medical
55.33%
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
76.95%
Soliton, Inc. stock logo
SOLY
Soliton
35.11%
Venus Concept Inc. stock logo
VERO
Venus Concept
87.41%
Beyond Air, Inc. stock logo
XAIR
Beyond Air
31.50%

Insider Ownership

CompanyInsider Ownership
Apyx Medical Corporation stock logo
APYX
Apyx Medical
16.80%
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
71.50%
Soliton, Inc. stock logo
SOLY
Soliton
12.00%
Venus Concept Inc. stock logo
VERO
Venus Concept
28.04%
Beyond Air, Inc. stock logo
XAIR
Beyond Air
19.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
Apyx Medical Corporation stock logo
APYX
Apyx Medical
27037.79 million31.45 millionOptionable
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
14067.27 million19.17 millionOptionable
Soliton, Inc. stock logo
SOLY
Soliton
1421.60 million19.01 millionNot Optionable
Venus Concept Inc. stock logo
VERO
Venus Concept
4101.42 million1.03 millionNot Optionable
Beyond Air, Inc. stock logo
XAIR
Beyond Air
7086.37 million69.61 millionOptionable

Recent News About These Companies

Beyond Air Inc.
Beyond Air granted U.S. patent for gaseous nitric oxide delivery
Beyond Air Gets Patent for Lung Infection Treatment

New MarketBeat Followers Over Time

Media Sentiment Over Time

Apyx Medical stock logo

Apyx Medical NASDAQ:APYX

$2.29 +0.14 (+6.70%)
Closing price 07/3/2025 02:07 PM Eastern
Extended Trading
$2.38 +0.08 (+3.53%)
As of 07/3/2025 04:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company's Helium Plasma Technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures various hand pieces for open and laparoscopic procedures; and OEM generators, as well as related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

Pulse Biosciences stock logo

Pulse Biosciences NASDAQ:PLSE

$14.80 -0.52 (-3.42%)
As of 07/3/2025 02:26 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.

Soliton stock logo

Soliton NASDAQ:SOLY

Soliton, Inc. is a medical development company, which engages in the development of healthcare technological devices for medical and cosmetic treatments. Its technology platform include Rapid Acoustic Pulse, a device uses rapid pulses of designed acoustic shockwaves to disrupt cellular structures in the dermal and subdermal tissue. The firm is also in the pre-revenue stage with its first products being developed for the removal of tattoos and the reduction of cellulite. The company was founded by Walter V. Klemp and Christopher Capelli on March 27, 2012 and is headquartered in Houston, TX.

Venus Concept stock logo

Venus Concept NASDAQ:VERO

$2.62 -0.34 (-11.36%)
Closing price 07/3/2025 03:51 PM Eastern
Extended Trading
$2.58 -0.03 (-1.15%)
As of 07/3/2025 04:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, back, thights, and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada.

Beyond Air stock logo

Beyond Air NASDAQ:XAIR

$0.18 +0.00 (+0.67%)
Closing price 07/3/2025 03:52 PM Eastern
Extended Trading
$0.18 0.00 (-0.56%)
As of 07/3/2025 04:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.